Effectiveness of Drug Use for Hemorrhagic Stroke Patients at RSUD dr. Soekardjo Tasikmalaya City
Jurnal Ilmiah Farmasi Farmasyifa · 01.08.2026 · 9 (2) · 217-224
DOI: 10.29313/jiff.v9i2.7833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Ilmiah Farmasi Farmasyifa, online erschienen am 01.08.2026. Verfasst von Yedy Purwandi Sukmawan und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Stroke represents the second leading cause of global mortality. Due to its poor prognosis, evaluating pharmacological regimens is essential to optimize outcomes and reduce mortality. This study evaluates drug utilization patterns and compares the effectiveness of regimens regarding in-hospital mortality at RSUD dr. Soekardjo.To evaluate drug utilization patterns and compare the effectiveness of various pharmacological regimens in reducing in-hospital mortality among hemorrhagic stroke patients. A retrospective observational cohort study was conducted using medical records of 194 patients hospitalized between January 2023 and September 2024. Effectiveness was analyzed using Relative Risk (RR) with 95% Confidence Intervals (CI). The study population was 50.5% male, with 51.6% of patients aged 60 years or older. The most prevalent regimens were the dual combination of mannitol and tranexamic acid (MA) and the triple combination of mannitol, citicoline, and tranexamic acid (MCA). Analysis revealed that tranexamic acid monotherapy carried a significantly higher mortality risk compared to the dual MA regimen (RR: 2.74; 95% CI: 1.36–5.49; p = 0.0046) and the triple MCA regimen (RR: 7.50; 95% CI: 1.07–52.38; p = 0.0422). No statistically significant difference in mortality was found between triple and dual combinations (RR: 0.67; p = 0.8198) or when comparing mannitol monotherapy to its combination counterparts. Pharmacological regimens incorporating 20% mannitol are the primary drivers of mortality reduction in this cohort. Adding citicoline or tranexamic acid to a mannitol base did not provide a statistically significant incremental survival benefit.
Zitieren
APA
Sukmawan, Y. P., Octavia, D. R., & Nofianti, T. (2026). Effectiveness of Drug Use for Hemorrhagic Stroke Patients at RSUD dr. Soekardjo Tasikmalaya City. Jurnal Ilmiah Farmasi Farmasyifa, 9(2), 217-224. https://doi.org/10.29313/jiff.v9i2.7833
Vancouver
Sukmawan YP, Octavia DR, Nofianti T. Effectiveness of Drug Use for Hemorrhagic Stroke Patients at RSUD dr. Soekardjo Tasikmalaya City. Jurnal Ilmiah Farmasi Farmasyifa. 2026;9(2):217-224. doi:10.29313/jiff.v9i2.7833
BibTeX
@article{Sukmawan2026,
author = {Sukmawan, Yedy Purwandi and Octavia, Diva Rachma and Nofianti, Tita},
title = {Effectiveness of Drug Use for Hemorrhagic Stroke Patients at RSUD dr. Soekardjo Tasikmalaya City},
journal = {Jurnal Ilmiah Farmasi Farmasyifa},
year = {2026},
volume = {9},
number = {2},
pages = {217--224},
doi = {10.29313/jiff.v9i2.7833}
}
EUVIMED